Age at Natural Menopause and Blood Pressure Traits: Mendelian Randomization Study
- PMID: 34640315
- PMCID: PMC8509463
- DOI: 10.3390/jcm10194299
Age at Natural Menopause and Blood Pressure Traits: Mendelian Randomization Study
Abstract
Observational studies suggest that early onset of menopause is associated with increased risk of hypertension. Whether this association is causal or due to residual confounding and/or reverse causation remains undetermined. We aimed to evaluate the observational and causal association between age at natural menopause (ANM) and blood pressure traits in Caucasian women. A cross-sectional and one-sample Mendelian randomization (MR) study was conducted in 4451 postmenopausal women from the CoLaus and Rotterdam studies. Regression models were built with observational data to study the associations of ANM with systolic and diastolic blood pressure (SBP/DBP) and hypertension. One-sample MR analysis was performed by calculating a genetic risk score of 54 ANM-related variants, previously identified in a genome-wide association study (GWAS) on ANM. In the two-sample MR analysis we used the estimates from the ANM-GWAS and association estimates from 168,575 women of the UK Biobank to evaluate ANM-related variants and their causal association with SBP and DBP. Pooled analysis from both cohorts showed that a one-year delay in menopause onset was associated with 2% (95% CI 0; 4) increased odds of having hypertension, and that early menopause was associated with lower DBP (β = -1.31, 95% CI -2.43; -0.18). While one-sample MR did not show a causal association between ANM and blood pressure traits, the two-sample MR showed a positive causal association of ANM with SBP; the last was driven by genes related to DNA damage repair. The present study does not support the hypothesis that early onset of menopause is associated with higher blood pressure. Our results suggest different ANM-related genetic pathways could differently impact blood pressure.
Keywords: age at menopause; blood pressure; hypertension; mendelian randomization analysis; menopause; systolic blood pressure.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Review of mendelian randomization studies on age at natural menopause.Front Endocrinol (Lausanne). 2023 Sep 11;14:1234324. doi: 10.3389/fendo.2023.1234324. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37766689 Free PMC article. Review.
-
Identifying potential causal effects of age at menopause: a Mendelian randomization phenome-wide association study.Eur J Epidemiol. 2022 Sep;37(9):971-982. doi: 10.1007/s10654-022-00903-3. Epub 2022 Sep 3. Eur J Epidemiol. 2022. PMID: 36057072 Free PMC article.
-
Age at first birth, age at menopause, and risk of ovarian cyst: a two-sample Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Jan 4;14:1279493. doi: 10.3389/fendo.2023.1279493. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38239975 Free PMC article.
-
Age at menarche, age at natural menopause, and risk of rheumatoid arthritis - a Mendelian randomization study.Arthritis Res Ther. 2021 Apr 9;23(1):108. doi: 10.1186/s13075-021-02495-x. Arthritis Res Ther. 2021. PMID: 33836822 Free PMC article.
-
Serum uric acid levels as a causal factor in hypertension: Insights from Mendelian randomization analysis.Clin Exp Hypertens. 2025 Dec;47(1):2496514. doi: 10.1080/10641963.2025.2496514. Epub 2025 May 5. Clin Exp Hypertens. 2025. PMID: 40325623 Review.
Cited by
-
Review of mendelian randomization studies on age at natural menopause.Front Endocrinol (Lausanne). 2023 Sep 11;14:1234324. doi: 10.3389/fendo.2023.1234324. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37766689 Free PMC article. Review.
-
Development and External Validation of a Home-based Risk Prediction Model of Natural Onset of Menopause-Teuta.J Clin Endocrinol Metab. 2024 Dec 18;110(1):e109-e116. doi: 10.1210/clinem/dgae125. J Clin Endocrinol Metab. 2024. PMID: 38442740 Free PMC article.
-
Obesity indicators as mediators of the association between age at menopause and blood pressure values.Hypertens Res. 2023 May;46(5):1100-1109. doi: 10.1038/s41440-023-01184-3. Epub 2023 Jan 26. Hypertens Res. 2023. PMID: 36702925
-
Mechanisms of ovarian aging in women: a review.J Ovarian Res. 2023 Apr 6;16(1):67. doi: 10.1186/s13048-023-01151-z. J Ovarian Res. 2023. PMID: 37024976 Free PMC article. Review.
-
Late age at menopause positively associated with obesity-mediated hypertension.Hypertens Res. 2023 May;46(5):1163-1164. doi: 10.1038/s41440-023-01237-7. Epub 2023 Feb 28. Hypertens Res. 2023. PMID: 36854726 No abstract available.
References
-
- Muka T., Oliver-Williams C., Kunutsor S., Laven J.S.E., Fauser B.C.J.M., Chowdhury R., Kavousi M., Franco O.H. Association of Age at Onset of Menopause and Time Since Onset of Menopause with Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol. 2016;1:767–776. doi: 10.1001/jamacardio.2016.2415. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources